Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dn1406131 (1 trial)
dn1508052 (1 trial)
Neoplasms (Phase 1)
Trials (2 total)
Trial APIs (2 total)